Additional effects of pioglitazone on type 2 diabetes who were inappropriately controled with
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000002333
- Lead Sponsor
- Department of Medicine, Metabolism and Endocrinology Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.the patients who had CVD or appoplexy within 6 months 2. the patients who have had hear failure (NYHA >III) 3. severe hepatic or renal failure 4. the patients who have had diabetic ketoacidosis 5. pregnant women 6. the pateints who has history of severe adverse effects with pioglitazone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.HbA1C as glycemic control 2.Total daily dose and number of insulin 3.change of IMT
- Secondary Outcome Measures
Name Time Method frequency of hypoglycemic attack